While the expression of CD112, CD137L, CD270, CD275, and GAL9 was barely detectable ion CD34− MM cells both before and after Rd treatment, these molecules were expressed in a significant proportion of CD34+ MM cells before treatment. The gene discussed is TNFSF9; the disease is Miyoshi myopathy.